Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Oratie Joep Killestein: Op weg naar precisie
jan 2019 | Multipele Sclerose